 |
On the 16th April 2023, BioSpectra Inc President Mr.Richard Mutchler and Shanco International James Wang coming to visit and audit our factory.All the staff of Yunbang extend a warm welcome to the customers coming from afar. As a high-tech enterprise specializing in R&D, production and sales of raw ... Read More
|
| |
Welcome to check our factory show: www.linked-reality.com/company/15472 Read More
|
| |
When it comes to biological buffers, the first thing that comes to mind is tris, also known as tris. The reason may be that tris is a very down-to-earth biochemical reagent, which has a wide range of uses and can be seen almost everywhere in daily life: it is an efficient skin care product ... Read More
|
| |
What are the characteristics of Tris? Tris hydroxymethyl aminomethane is also called Tris, CAS number: 77-86-1, white crystalline powder substance. The main function is to adjust or maintain the pH value of the solution in the range of 7-9 without changing the original properties of the substance. ... Read More
|
| |
How to configure edta disodium solution and precautions In clinical blood testing, edta disodium anticoagulant can be seen everywhere, which can effectively help improve efficiency and ensure test results, but it is not limited to this purpose, and can also be added to daily chemical cleaning ... Read More
|
| |
What are the preparation techniques of trishydroxymethylaminomethane hydrochloride? As a buffer commonly used in biochemical experiments, trishydroxymethylaminomethane hydrochloride has low ionic strength, good buffering effect, and can ensure the survival of proteins in a suitable pH environment, ... Read More
|
| |
|
| |
November 1, 2022 | Robust levels of large extracellular vesicles (LEVs) were found “hiding in plain sight” in the blood of early-stage breast cancer patients in a recent study led by a team of scientists at the University of Southern California (USC). The LEVs are roughly the size of a cell and ... Read More
|
| |
October 27, 2022 | Clinical whole exome sequencing services identify possible disease-causing genetic changes; a composite biomarker system uses multiple clinically relevant patient features to reflect the heterogeneity of graft failure; a regulatory science tool improves the review processes for ... Read More
|
| |
Evidence is emerging that long COVID (formally “post-acute sequelae SARS-CoV-2 infection,” or PASC) bears a striking, molecular-level resemblance to the disabling and complex illness now known as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). One key difference is that long COVID has ... Read More
|
